25 01, 2024

Humana Investors are Hurting After 14% Falloff Amidst Guidance Cuts: Why it May Be Time to Sell

By |2024-01-25T18:05:20+00:00January 25th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

Humana Inc. (HUM) is down more than 14% in Thursday’s trading session, as the losses keep piling up for investors over the past few weeks. The managed care company cut its guidance for 2024 while we’re not even out of January yet. Sky-high medical costs are taking a toll on the company, which has [...]

10 01, 2024

Baby Powder Lawsuits Hurt JNJ while Closing Several Acquisitions; Down 11% in 2023, Is it a Sell?

By |2024-01-10T19:20:12+00:00January 10th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Johnson & Johnson (JNJ) is known for baby products and the single-shot COVID-19 vaccine, making it a significant booster if you invested before the pandemic. However, following recent lawsuits, JNJ settled to pay $700 million following an investigation over its baby powder, while the COVID-19 vaccine was discontinued in the US, leading to an [...]

9 01, 2024

Why is Cardinal Health Falling After Announcing Upbeat Outlook? 3 Things Investors Need to Know

By |2024-01-09T17:38:41+00:00January 9th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Shares of Cardinal Health (CAH) fell more than 3% in Tuesday’s trading session despite the company announcing that it expects its full-year fiscal 2024 earnings to come in at the high range of its guidance.  The outlook in question is somewhere between $6.75 to $7 a share. Meanwhile, the FactSet consensus is $6.96. This [...]

4 01, 2024

Walgreens Falls 6% After Announcing Dividend Cuts Despite Solid Earnings: Should Investors Sell WBA?

By |2024-01-04T17:53:43+00:00January 4th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , , |

Shares of Walgreens (WBA) are down more than 6% in Thursday’s trading session after the drugstore retailer reported its fiscal first-quarter earnings. Earnings per share of 66 cents beat the consensus of 61 cents, while revenue of $36.71 billion topped the $34.86 billion expected. The company did report a net loss for the quarter [...]

3 01, 2024

Moderna Climbs 13% After Analyst Upgrades to a Buy: Why MRNA is Still Rated a Hold at VectorVest

By |2024-01-03T17:25:19+00:00January 3rd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Shares of Moderna (MRNA) climbed 13% in yesterday’s trading session after being upgraded to a buy at Oppenheimer. The stock fell a bit in Wednesday’s trading session, but has since settled at around even on the day. Hartaj Singh and a team of analysts see dramatic upside potential over the next few years for [...]

13 12, 2023

Pfizer Falls to 10-Year Low on Weak Forecast for 2024: 3 Reasons to Sell This Stock ASAP

By |2023-12-13T17:56:27+00:00December 13th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Pfizer (PFE) fell 9% in Wednesday morning trading after the company’s weak forecast for 2024 left much to be desired in the eyes of investors and analysts alike. The stock is headed toward a 10-year low, and has now shed 50% of its value in the last year alone. The drugmaker has been steadily [...]

27 11, 2023

Amphastar Pharmaceuticals, Inc. Powers Higher Towards Its August 9 All-Time High: Jump in Right Now?

By |2023-11-27T17:19:35+00:00November 27th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , , |

By Leslie N. Masonson, MBA Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH), is a bio-pharmaceutical firm, that develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products to its customers  in the United States, China, and France.  The company was incorporated in 1996 in Rancho Cucamonga, California where it is currently headquartered. It has [...]

23 10, 2023

Walgreens is Up 3% On Excitement Over New CEO & Bullish Outlook – VectorVest Still Says Sell

By |2023-12-07T19:49:26+00:00October 23rd, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , , , |

Shares of Walgreens Boots Alliance (WBA) started Monday morning trading strong with a 3% gain thus far. The stock has been battered in both the short and long term, but there is hope that new CEO Tim Wentworth will turn things around for the company. According to Lisa Gill, analyst at J.P. Morgan, today [...]

17 10, 2023

Johnson & Johnson Beats Earnings & Raises Forecast – So Why is the Stock Falling?

By |2023-12-07T19:49:36+00:00October 17th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Yesterday, we highlighted Pfizer’s challenges in pivoting as a post-pandemic company. Today, its competitor Johnson & Johnson (JNJ) reported earnings itself.  But, Johnson & Johnson painted an entirely different picture - beating out the earnings estimate on the top and bottom line while raising the forecast for the remainder of the year. The company [...]

16 10, 2023

Why is Pfizer Up 5% After Cutting Sales Outlook? 3 Things Investors Need to See

By |2023-12-07T19:49:39+00:00October 16th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Pfizer (PFE) ended last week on a sour note, announcing after the market closed on Friday that it will cut $9 billion from its sales outlook. And yet, the stock is up more than 5% so far in Monday morning’s trading session. The full-year EPS has been adjusted to $1.45 to $1.65 on revenue [...]

Go to Top